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One of the common causes of iron overload is excessive iron intake in cases of iron-poor anemia, where 
iron saccharate complex (ISC) is routinely used to optimize erythropoiesis. However, non-standardized 
ISC administration could entail the risk of iron overload. To induce iron overload, Wistar rats were intra-
peritoneally injected with subacute (0.2 mg kg–1) and subchronic (0.1 mg kg–1) overdoses of ISC for 2 
and 4 weeks, respectively. Iron status was displayed by an increase in transferrin saturation (up to 332%) 
and serum and liver iron burden (up to 19.3 μmol L–1 and 13.2 μmol g–1 wet tissue, respectively) togeth-
er with a drop in total and unsaturated iron binding capacities “TIBC, UIBC” as surrogate markers of 
transferrin activity. Iron-induced leukocytosis (up to 140%), along with the decline in serum transferrin 
markers (up to 43%), respectively, mark positive and negative acute phase reactions. Chemical stress was 
demonstrated by a significant rise (p > 0.05) in indices of the hemogram (erythrocytes, hemoglobin, 
hematocrit, leukocytes) and stress metabolites [corticosterone (CORT) and lactate]. Yet, potential causes 
of the unexpected decline in serum activities of ALT, AST and LDH (p > 0.05) might include decreased 
hepatocellular enzyme production and/or inhibition or reduction of the enzyme activities. The current 
findings highlight the toxic role of elevated serum and liver iron in initiating erythropoiesis and acute 
phase reactions, modifying iron status and animal organ function, changing energy metabolism and bring-
ing about accelerated glycolysis and impaired lactate clearance supposedly by decreasing anaerobic 
threshold and causing premature entering to the anaerobic system.
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INTRODUCTION
Iron supplements are used to treat states of increased requirements for erythropoetin-
stimulated red blood cell production. In case of iron overload, non-transferrin-bound 
iron eventually gets internalized into tissues because of the lack of regulating mecha-
nisms of iron excretion from the circulation [6]. Serum iron, total iron binding capac-
ity (TIBC), unsaturated iron binding capacity (UIBC) and percent transferrin satura-
tion are related indices that are routinely measured to assess the iron status of an 
animal and are widely used for the diagnosis of iron overload.
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The liver is at particular risk from iron-induced functional damage given that iron 
saturates the liver first before accumulating in other organs [6, 14]. Aspartate and 
alanine aminotransferases (AST and ALT, respectively) and lactate dehydrogenase 
(LDH) are enzymes released in serum in cases of hepatocellular injury [20]. Complete 
blood count (CBC) estimates primary and secondary medical conditions that affect 
the blood and bone marrow [8]. The stress hormone CORT is the principal glucocor-
ticoid involved in the regulation of stress responses in many species including 
rodents [21]. CORT in the blood is mostly unbound and can usually be demonstrated 
after few minutes, which makes plasma CORT a useful parameter for measurement 
of acute stress [27]. Lactate is another main effector in rodent stress system that helps 
organisms survive stressful situations [4].
Iron isomaltoside (Monofer®) is another new dextran-free parenteral iron product 
that is currently approved and is being marketed in several countries. However com-
paring this product with ISC, Toblli et al. [29] found that the iron isomaltoside caused 
more adverse effects in terms of biochemistry, oxidative stress, inflammatory markers 
and iron deposition in the liver, heart and kidneys of healthy rats than did ISC. But 
still excessive intake of ISC poses significant toxicity [6], which is very often, over-
looked in the fervor to correct anemia by giving these iron supplements. Current 
studies suggest that the recommended clinical iron dosage has to be revised sharply 
downward and that more studies have to be conducted to analyze the potential of 
human and animal ability to safely handle the stress of supplemental iron. Therefore, 
we herein recruited ISC as an iron supplement to induce iron overload based on ear-
lier reports on LD50 dosage in murine species. We examined the physiological 
changes elicited in male Wistar rat in response to subacute and subchronic intraperi-
tonial ISC overdoses. The objective of this study is to assess effects imposed upon the 
animal due to iron overload and to evaluate the animal’s iron status and the overall 
physiological health and functional competence.
MATERIALS AND METHODS
Drug
Iron saccharate complex (ISC) (Ferosac®, manufactured by SPIMACO, Saudi 
Pharma ceutical Industries and Medical Appliances Corporation, Saudi Arabia). The 
ISC formula does not contain dextran and has demonstrated a low incidence of 
adverse effects. 
Experimental animal and group allocation
A total number of 40 adult male Wistar albino rat, Rattus norvegicus, weighing 
150–180 g, was obtained from the animal house facility, King Saud University. In the 
lab, animals were housed in stainless steel rat cages (two per cage to avoid isolation 
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or overcrowding) under standard laboratory conditions (temperature, 24 ± 3 °C; 
humidity, 40–60%) with a 12-h light–dark cycle. Throughout the experimental dura-
tion, rats were given ad libitum access to tap water and commercially available rodent 
pelleted chow. After one week of acclimation, rats were randomly assigned into four 
groups, each of which (n = 10) received the specified dosage as an intraperitoneal 
injection. All rat groups received a daily dose of the specified treatment and were 
weighed twice a week. Rats of two control groups were injected with an isotonic 
saline solution (0.9% NaCl) over a period of 2 weeks (C1) or 4 weeks (C2). Animals 
of the Fe-subchronically and subacutely treated groups received ISC (100 mg Fe 
5 ml–1, Spimaco, Riyadh, KSA) in two dosages of 0.1 and 0.2 mg elemental iron/kg 
body weight over a period of 4 weeks and 2 weeks, respectively. The subacute and 
subchronic groups were compared to C1 and C2, respectively. The current Fe doses 
were based on earlier repeat-dose studies suggesting that iron dextran has a low toxic-
ity and that LD50 in mice is >2500 mg iron/kg [12]. Animal experiments were con-
ducted in accordance with the guidelines of the National Committee for Medical and 
Bio-ethics, PO Box 6086, 11442, Riyadh, Saudi Arabia and the policy and standard 
guidelines for ethical conduct in the care and use of nonhuman animals in 
research [15].
Blood sampling and preparation for analysis 
At the end of the experimental period, animals were anesthetized by inhalation of 
CO2. Blood samples were obtained from the retro-orbital venous plexus using a cap-
illary pipette method [30], in which blood is allowed to flow by capillary action into 
a microhematocrit capillary tube. During handling procedures, blood samples were 
maintained at 5 °C. From each rat, two blood samples were withdrawn, one for whole 
blood analysis and the second for serum analysis. Blood samples allocated for whole 
blood analysis were stored in commercially available anticoagulant-treated tubes 
(EDTA-coated) and kept at –20 °C pending rapid blood count.
Blood samples allocated for serum analysis were stored in sterile closed non-hep-
arinized tubes and left undisturbed to clot for 30 min at room temperature. The clot 
was then gently rotated with a wooden applicator and samples were centrifuged 
(Macro Biofuge Stratos centrifuge, Heraeus instruments, Germany) at 1400× g for 15 
min. The clear supernatant serum was aspirated using a Pasteur pipette and appor-
tioned into 0.5 ml aliquots into sterile serum tubes. Tubes were then snap-frozen and 
stored in liquid nitrogen at –70 °C pending analysis. All blood analysis was done in 
laboratory within 24 h, whereas serum lactate was performed immediately within 30 
minutes of collection. 
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Quantification of blood indices
Whole blood was analyzed for the selected indices using a Beckman Coulter LH 750 
Hematology Analyzer (Fullerton, CA, USA). In non-hemolyzed serum, TIBC, AST, 
ALT, LDH, CORT and lactate were determined spectrophotometrically with com-
mercial assay kits. Serum iron concentration was detected using atomic absorption 
spectroscopy (Varian Chrompack International, Australia). The Dade Behring 
Dimension RXL MAX chemistry analyzer (Deerfield, IL 60015, USA) was used to 
determine AST, ALT, LDH, TIBC and lactate; whereas CORT was determined using 
Victor™2 1420 multilabel counter plate reader for photometry (Perkin Elmer Wallac, 
Turku, Finland). 
Serum iron, AST, ALT, LDH and CORT were determined using commercially 
available kits (Siemens Healthcare Diagnostics Ltd., Camberly, Surrey, UK). Serum 
iron concentration was determined according to ICSH [16] at a wavelength of 562 
nm. Serum TIBC was measured spectrophotometrically [17] at a wavelength 520 nm. 
Unsaturated iron binding capacity (UIBC) is calculated by subtracting the serum iron 
from the TIBC. Percent transferrin saturation is calculated using values of serum iron 
and TIBC (% transferrin saturation = 100 × serum iron/TIBC). Serum AST and ALT 
were assayed colorimetrically [24] at 340 nm. Serum LDH was assayed according to 
Babson and Babson [3] at 340 nm. Total serum CORT was quantified according to 
Al-Dujaili et al. [2] using the commercially available Coat-A-Count rat CORT radio-
immunoassay kit (Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA) 
as per the manufacturer’s instructions. Quantitative determination of D-lactate 
(D-lactic acid) was performed in serum using the colorimetric D-lactate assay kit 
(Eton Bioscience, San Diego, CA) at 490 nm according to the manufacturer’s instruc-
tions. 
Determination of hepatic iron
Immediately after blood sampling, animals were sacrificed and livers were excised 
and cut into small pieces, placed in borosilicate tubes, and stored at –80 °C until later 
used. Thawed liver material was digested in 7 ml of HNO3 65% and 1 ml H2O2 30% 
by a closed-vessel microwave wet digestion method method [19] for the metal deter-
mination [33] using atomic absorption spectroscopy (Varian Chrompack International, 
Australia). 
Data processing
Results were expressed as mean ± standard error (SE). Comparisons of data of exper-
imental groups with the control group were performed with unpaired t-test (student’s 
t-test) using GraphPad Prism software (GraphPad Software, Inc. La Jolla, CA). 
Differences at p < 0.05 were considered significant. 
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RESULTS
Effects of iron overload on hepatic iron accumulation
Liver mean iron concentration in rats was obviously higher in both subacutely 
(p > 0.01) and subchronically (p > 0.001) treated groups (7.20 ± 0.79 and 13.19 ± 0.97 
μmol g–1 fresh tissue, respectively) than corresponding control subjects (2.04 ± 0.34 
and 2.12 ± 0.36 μmol g–1 fresh tissue, respectively) (Table 1). Iron burden in liver was 
elevated in subchronic group by 354%. Even more, iron concentration in hepatic tis-
sue of rats in subacute group grew by 621% above control. Concisely, a lower 
subchronic dose (0.1 mg kg–1) given over a longer period (4 weeks) showed more 
profound hepatic iron burden than a higher subacute dose (0.2 mg kg–1) given over 
a shorter period (2 weeks).
Effects of iron overload on components of the CBC and serum enzymes 
and metabolites 
Iron overdose was accompanied by a general significant (p > 0.05) increase in all 
blood cell indices versus control subjects (Fig. 1). Mean values for count of RBCs for 
the groups subacute, subchronic and their two respective controls were 7.97 ± 0.8, 
7.76 ± 0.9, 6.20 ± 0.6 and 6.40 ± 0.5×10³ µL–1, respectively. Those for HCT were 
44.89 ± 3.9, 44.2 ± 5.1, 38.1 ± 4.1 and 37.8 ± 3.9 %, respectively. For Hb, the values 
were 15.38 ± 1.21, 15.3 ± 1.1, 13.73 ± 0.9 and 13.9 ± 1.0 g dL–1, respectively. Mean 
values for total WBC count were 16.4 ± 1.3, 13.72 ± 1.2, 11.73 ± 0.9 and 12.0 ± 1.1× 
10³ µL–1, respectively). TIBC and UIBC of subacute and subchronic groups showed 
a significant (p > 0.05) drop compared to control levels (Table 1) drawing a negative 
correlation with the significant increase reported for iron accumulation in the liver 
Table 1
Effects of iron overload on iron status in male albino rat
C1 Subacute C2 Subchronic
Hepatic iron 2.035 ± 0.357 7.197 ± 0.786** 2.121 ± 0.364 13.186 ± 0.973***
TIBC 81.610 ± 6.195 66.610 ± 8.385* 80.770 ± 5.645 60.9 ± 8.195*
Serum iron 7.2 ± 0.81 15.5 ± 1.7* 7.7 ± 0.76 19.3 ± 2.1*
UIBC 72.5 ± 7.9 54.3 ± 6.0* 74.5 ± 8.3 42.7 ± 5.1*
% TS 9.2 ± 0.97 24.3 ± 2.9* 8.8 ± 0.9 29.2 ± 3.5 *
% increase TS 264 332
Tabulated values represent mean ± SE concentrations of hepatic iron (μmol g–1 wet tissue), serum iron 
(μmol L–1), TIBC (μmol L–1), UIBC (μmol L–1) of rats intraperitoneally injected with subacute (0.2 mg kg–1) 
and subchronic (0.1 mg kg–1) overdoses of ISC for 2 and 4 weeks, respectively. TS stands for transferrin satura-
tion; C1 and C2 refer to corresponding controls for subacute and subchronic groups, respectively. Asterisks 
indicate significant (*p > 0.05), highly significant (**p > 0.01) and very highly significant (***p > 0.001) differ-
ences from control values.
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(p > 0.01 – p > 0.001) and in serum (p > 0.05) that amounted to 3.5- and 2.2-fold in 
subacute and 6.2 and 2.5 in subchronic groups, in a respective order. Also, Table 1 
shows 2.7- and 3.3-fold increase in % transferrin saturation in subacute and sub-
chronic groups, respectively. 
As a principal glucocorticoid effector of the stress response system in rodents, 
CORT mean serum concentrations showed a significant (p > 0.05) increase in suba-
cute and subchronic rat groups (45.0 ± 4.9 and 44.7 ± 3.8 nmol L–1, respectively) 
versus control subjects (37.8 ± 4.1 and 38.1 ± 3.7 nmol L–1, respectively) (Fig. 2). This 
was attended by a similar increase (p > 0.05) in the mean circulating level of lactate 
concentrations in rats subacutely and subchronically injected with Fe (8.37 ± 0.7 and 
7.96 ± 0.7 mmol L–1, respectively) compared to control rat group (6.89 ± 0.5 and 
6.8 ± 0.4 mmol L–1, respectively).
The common rule governing serum changes of organ function enzymes is a sig-
nificant (p > 0.05) decrease in the activities of AST, ALT and LDH after subacute 
(118.3, 45.2 and 792.75 UL–1, respectively) and subchronic (132.0, 51.0 and 761.38 
UL–1, respectively) treatment compared to parallel controls (subacute: 129.2, 62.5 
and 834.25 UL–1, respectively; subchronic: 133.15, 64.0 and 829.56 UL–1, respec-
tively) (Fig. 3, Table 3).
Fig. 1. Effects of iron overload on acute phase reactants in male Wistar rat. Data represent mean ± SE 
blood counts of RBC (×10³ µL–1), Hb (g dL–1), HCT (%) and WBCs (×10³ µL–1) of rats intraperitoneally 
injected with subacute (Subacu, 0.2 mg kg–1) and subchronic (subchr, 0.1 mg kg–1) overdoses of ISC for 
2 and 4 weeks, respectively. C1 and C2 refer to corresponding controls for subacute and subchronic 
groups, respectively. Asterisks indicate significant (*p > 0.05) differences from control values
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Fig. 2. Effects of iron overload on acute phase reactants in male Wistar rat. Data represent mean ± SE 
serum concentrations of CORT (nmol L–1) and lactate (mmol L–1) of rats intraperitoneally injected with 
subacute (Subacu, 0.2 mg kg–1) and subchronic (subchr, 0.1 mg kg–1) overdoses of ISC for 2 and 4 weeks, 
respectively. C1 and C2 refer to corresponding controls for subacute and subchronic groups, respectively. 
Asterisks indicate significant (*p > 0.05) differences from control values
Table 2
Effects of iron overload on the induction of serum malondialdehyde (MDA) (μmol L–1) as a measure of 
lipid peroxidation and oxidative stress in male albino rat. Tabulated data were reported in an integral 
part of the current experiment [1]
Groups
C1 Subacute C2 Subchronic
MDA 0.359 ± 0.05995 1.170 ± 0.3194** 0.410 ± 0.066 2.120 ± 0.3544***
Rats were intraperitoneally injected with subacute (0.2 mg kg–1) and subchronic (0.1 mg kg–1) overdoses of ISC 
for 2 and 4 weeks, respectively. C1 and C2 refer to corresponding controls for subacute and subchronic groups, 
respectively. Asterisks denote highly (**p > 0.01) and very highly significant (***p > 0.001) differences from 
control values.
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Fig. 3. Effects of iron overload on hepatic function in male albino Wistar rat. Data represent mean ± SE 
serum activities (UL–1) of AST, ALT and LDH of rats intraperitoneally injected with subacute (Subacu, 
0.2 mg kg–1) and subchronic (subchr, 0.1 mg kg–1) overdoses of ISC for 2 and 4 weeks, respectively. C1 
and C2 refer to corresponding controls for subacute and subchronic groups, respectively. Asterisks indi-
cate significant (*p > 0.05) differences from control values
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DISCUSSION
Erythropoiesis and iron status
Evidence for iron toxicity of the liver is presented by the remarkable elevation of Fe 
concentration in the liver tissue, observed following subacute (3.5-fold) (p > 0.01) and 
subchronic (6.2-fold) (p > 0.001) iron application (Table 1). Clinical proof of liver 
iron toxicity was similarly shown as a 4.5-fold increase in liver iron stores in humans 
receiving intramuscular iron dextran injections [28]. The basic hypothesis behind this 
is the lack of regulating mechanisms of iron excretion from the circulation and the 
unlikelihood of a spontaneous removal of excess iron. Essentially all circulating 
plasma iron is bound to transferrin [6]. Although at least eighty percent of the iron 
bound to circulating transferrin is delivered to the bone marrow and incorporated into 
newly formed erythrocytes, the liver is one of the major other sites of iron delivery 
[6]. In the current intraperitoneal polysaccharide preparations, elemental iron is 
unlikely to join directly the transferrin pool [9] as in case of dietary iron. Iron-
polysaccharide complexes might undergo phagocytosis by macrophages, which pro-
cess iron, clear it from the polysaccharide cage and export it to the circulation for 
binding to transferrin or store it within ferritin [22]. Although iron recycling by mac-
rophages is one of the least well-understood areas of iron metabolism, there are 
reports suggesting that iron-laden macrophages may spill over excessive iron to 
hepatocytes [5].
The drop in UIBC and TIBC attended by the rise in % transferrin saturation and 
liver and serum iron is coincident with the onset of lipid peroxidation and oxidative 
stress shown in an integral part of this experiment [1]. This could indicate that the 
ability of transferrin to safely bind serum iron is impaired, not only because the iron 
stores are elevated and there is limited capacity for transferrin molecules to accept 
additional iron, but also because, as an acute-phase reactant, transferrin activity could 
be altered in the presence of chemical stress [23].
As expected, all studied indices of the red blood cell count (RBCs, HCT, Hb and 
WBC) of both subacute or subchronic Fe-overdosed rats exhibited a significant 
(p > 0.05) rise versus corresponding control values. In parenteral iron application, 
iron-carbohydrate agents mix with plasma before entering the reticuloendothelial 
Table 3
Effects of iron overload on the indices ALT/LDH and AST/ALT in male albino Wistar rat
C1 Subacute C2 Subchronic
ALT-LDH index 0.075 0.057 0.077 0.067
AST-ALT index 2.067 2.617 2.081 2.726
Data represent the ratios ALT/LDH and AST/ALT in rats intraperitoneally-injected with subacute (0.2 mg kg–1) 
and subchronic (0.1 mg kg–1) overdoses of ISC for 2 and 4 weeks, respectively. C1 and C2 refer to correspond-
ing controls for subacute and subchronic groups, respectively.
370 Khadiga g. adham et al.
Acta Biologica Hungarica 66, 2015
system, where resident phagocytes of the liver, spleen, and bone marrow remove iron 
agent from the circulating plasma [14]. Within phagocytes, iron is released from the 
iron-carbohydrate compound into a low molecular weight iron pool, whence iron is 
either incorporated by ferritin into intracellular iron stores or is released from the cell 
to be taken up by the extracellular iron-binding protein transferrin. Transferrin deliv-
ers iron to transferrin receptors on the surface of erythroid precursors, and the result-
ing internalization of the iron-transferrin-transferrin receptor complex supplies iron 
for hemoglobin synthesis and maturation of red cell [10], hence elevating red blood 
cell indices. 
The more pronounced leukocytosis in subacute (140%) than in subchronic (114%) 
setting versus control might be mediated by the co-ordinated actions of cytokines/
chemokines [11] in response to iron-induced oxidative stress [1] (see Table 2). 
Excessive iron status was earlier shown to be associated with an increase in cytokine/
chemokine in hepatic acini in rats [11], eventually leading to several events like 
increased release of leukocytes from bone marrow pools, decreased margination of 
leukocytes onto vessel walls, decreased extravasation of leukocytes from the vessels 
into tissues and increased number of precursor cells in the marrow [18]. This iron-
induced leukocytosis, along with the decline in TIBC “the surrogate marker of trans-
ferrin activity” could, respectively, mark positive and negative acute phase reactions.
Organ function and metabolic stress
Because serum aminotransferase levels are commonly used to screen for liver dis-
ease, recognition of liver damage may be hampered by the reduction in aminotrans-
ferase values. Although the biological significance of this decrease in rodents is 
unclear, Waner and Nyska [32] concluded that until the mechanism of effect of a 
particular drug or chemical is understood, reduced aminotransferase activities should 
not be ignored or side-stepped as being within the normal range or of no biological 
significance. Even though studies aimed to clarify the pathogenesis of this phenom-
enon are in progress, potential causes of decreased serum activities of ALT, AST and 
LDH are reported to include decreased hepatocellular production or release of the 
enzymes, inhibition or reduction of the enzymes activity and/or congestion in the 
hepatic centrolobular area [31]. 
Taken together, the two common ratios AST-ALT and ALT-LDH might reflect 
stress-related tissue damage in subacutely and subchronically iron-overdosed rats, 
where the former index increased and the latter decreased in both rat groups 
(Table 3). According to Sánchez et al. [25] increased AST-ALT ratio was diagnostic 
of tissue injury induced by acute stress in mice, while the rise in the index ALT-LDH 
was found significant for the prognosis of acute liver injury [20]. 
Data of the present study indicate a significant (p > 0.05) increase in serum concen-
trations of CORT in both Fe-subacutely and subchronically treated rats versus control 
subjects. This rise could point out an adaptive response helping the animal to cope 
with the stressful physiological episode of iron overload until it subsides via a nega-
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tive feedback mechanism. Vertebrates normally respond to the onset of an acute 
stressor with an acute increase in plasma glucocorticoids [26]. The suggested mecha-
nism implies activation of the hypothalamus-pituitary-adrenal axis by the iron over-
load stressful condition leading to the release of the glucocorticoid CORT from the 
adrenal cortex into the blood [13] where it crosses the blood brain barrier and regu-
lates its own release via negative feedback acting on glucocorticoid receptors in the 
hypothalamus [13]. 
A potentially important physiological response to stress may be alteration in the 
gross regulation of energy metabolism. Although hyperlactatemia is frequently used 
to diagnose inadequate tissue oxygenation, other processes not related to tissue oxy-
genation may increase lactate levels. The current hyperlactatemia mostly refers to 
lactate potential to serve as a critical buffer allowing glycolysis to accelerate when 
large additional amounts of energy are rapidly required under circumstances of iron-
induced cellular stress [4]. Iron-induced hyperlactatemia could thus be due to 
impaired lactate clearance rather than hypoxic tissue production of lactate [7]. 
Lactate is a crucial metabolite in the two main ATP-producing processes, glycoly-
sis and oxidative phosphorylation. Both processes steadily metabolize glucose when 
conditions are stable with pyruvate as the molecule that links these two reactions. 
Under stressful conditions, glycolysis can increase by a factor 100 to 1,000, provided 
that glucose is present and pyruvate is converted to lactate. Because the rate of gly-
colysis can increase faster by several orders of magnitude than oxidative phospho-
rylation, glycolysis can briefly provide far more ATP when most required under stress 
conditions. Excess pyruvate will rapidly accumulate and is diverted to lactate in order 
for glycolysis to proceed [4]. It could be concluded that the observed hyperlactatemia 
is due to decreased anaerobic threshold and premature entering the anaerobic system 
with accelerated glycolysis that overwhelms lactate utilization and clearance. 
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